Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.

To assess incidence charges (IRs) of VTE in patients with rheumatoid arthritis (RA) on completely different DMARDs and DMARD switchers.Adults with RA on a DMARD between 2007 and 2017 have been studied in a US claims database.

Conventional synthetic DMARD (csDMARD) customers, first biologic/targeted synthetic DMARD (b/tsDMARD) customers and b/tsDMARD switchers (from a b/tsDMARD to a different b/tsDMARD) have been adopted for inpatient VTE (pulmonary embolism (PE)/deep vein thrombosis (DVT)).

Crude and adjusted IR and 95% CIs of VTE have been estimated. HRs for VTE have been estimated through Cox regression. VTE danger was additionally evaluated by quantity of switches between b/tsDMARDs and in patients and not using a VTE historical past.

The age and intercourse standardised IR (95% CI) of VTE (per 100 person-years) was 0.86 (0.70 to 1.03), 0.60 (0.52 to 0.68) and 0.58 (0.51 to 0.65) for b/tsDMARD switchers, first b/tsDMARD customers and csDMARD customers, respectively. After adjustment, b/tsDMARD switchers had an elevated danger of VTE, in contrast with csDMARD customers, HR_adj (95% CI) being 1.36 (1.16 to 1.58), 1.36 (1.13 to 1.63) and 1.47 (1.18 to 1.83) for VTE, DVT and PE, respectively.

Compared with first b/tsDMARD customers, the HR_adj (95% CI) for VTE was 1.35 (1.15 to 1.60) for first b/tsDMARD switchers and 1.48 (1.19 to 1.85) for second b/tsDMARD switchers.In RA, b/tsDMARD switchers have the next VTE danger in contrast with csDMARD customers and first b/tsDMARD customers.

Serologically Defined Colon Cancer Antigen 3 (SDCCAG3) Antibody
abx237665-100ug	Abbexa	100 ug	EUR 610.8

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx237666-100ug	Abbexa	100 ug	EUR 577.2

Serologically defined colon cancer antigen 3 (SDCCAG3) Antibody
20-abx213359	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Serologically defined colon cancer antigen 3 (SDCCAG3) Antibody
20-abx213492	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
20-abx121727	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
20-abx325189	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Serologically Defined Colon Cancer Antigen 3 (SDCCAG3) Antibody
20-abx115457	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
20-abx115458	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx029545-400ul	Abbexa	400 ul	EUR 627.6

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx029545-80l	Abbexa	80 µl	EUR 343.2

Serologically defined colon cancer antigen 3 (SDCCAG3) Antibody
20-abx334226	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx432203-200ul	Abbexa	200 ul	EUR 460.8

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx432204-200ul	Abbexa	200 ul	EUR 343.2

Serologically Defined Colon Cancer Antigen 3 (SDCCAG3) Antibody
20-abx005975	Abbexa	EUR 493.20 EUR 710.40 EUR 376.80	100 ul 200 ul 50 ul

Serologically defined colon cancer antigen 3 (SDCCAG3) Antibody (HRP)
20-abx337646	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Serologically defined colon cancer antigen 3 (SDCCAG3) Antibody (FITC)
20-abx337647	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Serologically defined colon cancer antigen 3 (SDCCAG3) Antibody (Biotin)
20-abx337648	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

anti- IDI1 antibody
FNab04124	FN Test	100µg	EUR 606.3
Description: Antibody raised against IDI1

anti- IDI2 antibody
FNab04125	FN Test	100µg	EUR 702
Description: Antibody raised against IDI2

anti- DEF6 antibody
FNab02325	FN Test	100µg	EUR 606.3
Description: Antibody raised against DEF6

ELISA kit for Human Serologically defined colon cancer antigen 3
EK3827	SAB	96 tests	EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Serologically defined colon cancer antigen 3 in samples from serum, plasma, tissue homogenates and other biological fluids.

Cow Serologically defined colon cancer antigen 3 (SDCCAG3) ELISA Kit
abx517987-96tests	Abbexa	96 tests	EUR 1093.2

Anti-IBP / DEF6 antibody
STJ70543	St John's Laboratory	100 µg	EUR 430.8

anti- DEFA1 antibody
FNab02326	FN Test	100µg	EUR 702
Description: Antibody raised against DEFA1

anti- DEFB1 antibody
FNab02327	FN Test	100µg	EUR 702
Description: Antibody raised against DEFB1

Human Serologically defined colon cancer antigen 3 (SDCCAG3) ELISA Kit
abx251171-96tests	Abbexa	96 tests	EUR 801.6

Human Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) ELISA Kit
abx383072-96tests	Abbexa	96 tests	EUR 1093.2

Mouse Serologically defined colon cancer antigen 3 (SDCCAG3) ELISA Kit
abx517989-96tests	Abbexa	96 tests	EUR 801.6

Human SDCCAG3(Serologically defined colon cancer antigen 3) ELISA Kit
EH1858	FN Test	96T	EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.938 ng/ml

Human SDCCAG3/ Serologically defined colon cancer antigen 3 ELISA Kit
E2842Hu	Sunlong	1 Kit	EUR 685.2

anti- DEFB4A antibody
FNab09962	FN Test	100µg	EUR 658.5
Description: Antibody raised against DEFB4A

anti- DEFB4A antibody
LSMab09962	Lifescience Market	100 ug	EUR 463.2

anti- DEFB121 antibody
FNab02328	FN Test	100µg	EUR 702
Description: Antibody raised against DEFB121

Anti-DEFB106A / DEF106B (aa47-59) antibody
STJ72658	St John's Laboratory	100 µg	EUR 312

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody
20-abx311940	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody
20-abx135805	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
abx234923-100ug	Abbexa	100 ug	EUR 577.2

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
abx234924-100ug	Abbexa	100 ug	EUR 661.2

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody
abx234926-100ug	Abbexa	100 ug	EUR 577.2

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx211767	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx321660	Abbexa	EUR 360.00 EUR 292.80	100 ul 50 ul

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
abx331031-100ul	Abbexa	100 ul	EUR 510

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx113577	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody
20-abx113578	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx324057	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx320117	Abbexa	EUR 360.00 EUR 292.80	100 ul 50 ul

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
abx431997-200ul	Abbexa	200 ul	EUR 460.8

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx001424	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx015210	Abbexa	EUR 376.80 EUR 117.60 EUR 477.60 EUR 594.00	100 ug 10 ug 200 ug 300 µg

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
abx145441-100ug	Abbexa	100 ug	EUR 469.2

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody
abx145476-100ug	Abbexa	100 ug	EUR 469.2

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody
20-abx301384	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
20-abx213689	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
20-abx213948	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
20-abx211500	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
20-abx211688	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody
20-abx211874	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody
20-abx211875	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
20-abx211876	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
20-abx212135	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody
20-abx333903	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
abx037320-100ug	Abbexa	100 ug	EUR 469.2

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
abx033148-400ul	Abbexa	400 ul	EUR 627.6

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
abx033148-80l	Abbexa	80 µl	EUR 343.2

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
20-abx129026	Abbexa	EUR 510.00 EUR 159.60 EUR 1446.00 EUR 693.60 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody
20-abx124266	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
20-abx328331	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
20-abx002006	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody
20-abx008052	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

WNK Lysine Deficient Protein Kinase 3 (WNK3) Antibody
20-abx004266	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody
20-abx302326	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody (HRP)
20-abx311941	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody (HRP)
20-abx306960	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Anti-beta Defensin 1/DEFB1 Antibody
PA1450	BosterBio	100ug/vial	EUR 400.8

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody (HRP)
20-abx316621	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody (FITC)
20-abx311942	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody (HRP)
20-abx337640	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody (FITC)
20-abx306961	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

IDI1 antibody
22782-100ul	SAB	100ul	EUR 468

IDI2 Antibody
39580-100ul	SAB	100ul	EUR 468

IDI1 antibody
70R-12958	Fitzgerald	100 ul	EUR 548.4
Description: Affinity purified Rabbit polyclonal IDI1 antibody

IDI1 antibody
70R-17881	Fitzgerald	50 ul	EUR 522
Description: Rabbit polyclonal IDI1 antibody

IDI2 antibody
70R-17882	Fitzgerald	50 ul	EUR 522
Description: Rabbit polyclonal IDI2 antibody

IDI1 antibody
70R-3705	Fitzgerald	50 ug	EUR 560.4
Description: Rabbit polyclonal IDI1 antibody raised against the middle region of IDI1

IDI2 antibody
31932-100ul	SAB	100ul	EUR 302.4

IDI2 antibody
31932-50ul	SAB	50ul	EUR 224.4

IDI1 Antibody
DF13081	Affbiotech	200ul	EUR 420

IDI2 Antibody
1-CSB-PA871603LA01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against IDI2. Recognizes IDI2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

IDI1 Antibody
1-CSB-PA010994GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against IDI1. Recognizes IDI1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

IDI2 Antibody
1-CSB-PA010995GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against IDI2. Recognizes IDI2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody (FITC)
20-abx316622	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody (FITC)
20-abx337641	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Anti-Alpha Defensin 1/DEFA1 Antibody
A10546	BosterBio	100ug/vial	EUR 352.8

Anti-DEFB107A / DEFB107B antibody
STJ72659	St John's Laboratory	100 µg	EUR 430.8

Anti-DEFB103A / DEFB103B antibody
STJ72660	St John's Laboratory	100 µg	EUR 312

Polyclonal Goat Anti-IBP / DEF6 Antibody
APR16306G	Leading Biology	0.1 mg	EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-IBP / DEF6 . This antibody is tested and proven to work in the following applications:

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody (Biotin)
20-abx311943	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Mitotic Arrest Deficient 2 Like 1 (MAD2L1) Antibody (Biotin)
20-abx306962	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
abx235058-100ug	Abbexa	100 ug	EUR 577.2

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
abx235059-100ug	Abbexa	100 ug	EUR 577.2

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
abx235060-100ug	Abbexa	100 ug	EUR 577.2

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
abx235062-100ug	Abbexa	100 ug	EUR 577.2

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx225288	Abbexa	EUR 444.00 EUR 727.20 EUR 376.80	100 ul 200 ul 50 ul

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx109729	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx173582	Abbexa	EUR 978.00 EUR 510.00	1 mg 200 ug

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx173583	Abbexa	EUR 1028.40 EUR 526.80	1 mg 200 ug

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx177570	Abbexa	EUR 526.80 EUR 159.60 EUR 1479.60 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx177571	Abbexa	EUR 543.60 EUR 159.60 EUR 1562.40 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx212230	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx212332	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx212341	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx212359	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
20-abx212363	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx213180	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx213339	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx210542	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx211913	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
20-abx325822	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx321528	Abbexa	EUR 360.00 EUR 292.80	100 ul 50 ul

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx321722	Abbexa	EUR 360.00 EUR 292.80	100 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx322275	Abbexa	EUR 360.00 EUR 292.80	100 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
abx332335-100ul	Abbexa	100 ul	EUR 510

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
abx332336-100ul	Abbexa	100 ul	EUR 510

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
abx332447-100ul	Abbexa	100 ul	EUR 510

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx326200	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx327610	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx113755	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx113756	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
20-abx113758	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx113759	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx113761	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
abx027744-400ul	Abbexa	400 ul	EUR 627.6

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
abx027744-80l	Abbexa	80 µl	EUR 343.2

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
abx028121-400ul	Abbexa	400 ul	EUR 627.6

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
abx028121-80l	Abbexa	80 µl	EUR 343.2

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
abx028737-400ul	Abbexa	400 ul	EUR 627.6

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
abx028737-80l	Abbexa	80 µl	EUR 343.2

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx126969	Abbexa	EUR 493.20 EUR 710.40	100 ul 200 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx128636	Abbexa	EUR 510.00 EUR 159.60 EUR 1446.00 EUR 693.60 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Minichromosome Maintenance Deficient 2 (MCM2) Antibody
20-abx129081	Abbexa	EUR 493.20 EUR 159.60 EUR 1378.80 EUR 678.00 EUR 376.80	100 ug 10 ug 1 mg 200 ug 50 ug

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx323744	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
20-abx338830	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx320233	Abbexa	EUR 360.00 EUR 292.80	100 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx329450	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
abx432951-200ul	Abbexa	200 ul	EUR 343.2

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
abx432952-200ul	Abbexa	200 ul	EUR 343.2

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
20-abx002188	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Minichromosome Maintenance Deficient 4 (MCM4) Antibody
20-abx009002	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Minichromosome Maintenance Deficient 3 (MCM3) Antibody
20-abx000983	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
20-abx001052	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx004255	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
20-abx013138	Abbexa	EUR 376.80 EUR 117.60 EUR 477.60 EUR 594.00	100 ug 10 ug 200 ug 300 µg

Minichromosome Maintenance Deficient 7 (MCM7) Antibody
abx145477-100ug	Abbexa	100 ug	EUR 469.2

Minichromosome Maintenance Deficient 5 (MCM5) Antibody
abx145478-100ug	Abbexa	100 ug	EUR 469.2

WNK Lysine Deficient Protein Kinase 1 (WNK1) Antibody (Biotin)
20-abx316623	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

WNK Lysine Deficient Protein Kinase 2 (WNK2) Antibody (Biotin)
20-abx337642	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

SCO Cytochrome Oxidase Deficient Homolog 2 (SCO2) Antibody
20-abx129130	Abbexa	EUR 543.60 EUR 159.60 EUR 1562.40 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Sco Cytochrome Oxidase Deficient Homolog 1 (Yeast) Antibody
20-abx115390	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Sco Cytochrome Oxidase Deficient Homolog 2 (Yeast) Antibody
20-abx115391	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Minichromosome Maintenance Deficient 4 (MCM4) Antibody (HRP)
20-abx335415	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Switching b/tsDMARDs could also be a proxy for increased illness severity or poorly managed RA and an vital confounder to contemplate in acquiring unbiased estimates of VTE danger in observational RA security research.

Cardiovascular danger of synthetic, non-biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

Patients with rheumatoid ailments have an elevated danger of CVD and CVD-related dying in contrast with the basic inhabitants. Both the conventional cardiovascular danger elements and systemic irritation are contributors to this phenomenon. This evaluate examines the obtainable proof about the results of synthetic, non-biologic disease-modifying antirheumatic drugs (DMARDs) in CVD danger.

This is a crucial situation for clinicians when deciding on particular person remedy plans in patients with rheumatic ailments. Evidence means that synthetic, non-biologic DMARDs similar to methotrexate, sulfosalazine, hydroxychloroquine, leflunomide and tofacitinib present decreased CVD morbidity and mortality. However, the strongest knowledge in favor of a discount in CVD occasions in rheumatoid patients are proven with methotrexate which has been the focus of most research.

Adequate proof for a beneficial impact additionally exists for hydroxychlorokine. Larger, potential research and randomized scientific trials are wanted to raised characterize the impact of synthetic, non-biologic DMARDs on CVD outcomes in these patients.

Design of future research ought to embody areas with lack of proof, similar to the danger for coronary heart failure, arrhythmias and valvular coronary heart illness. The clinically related query whether or not synthetic, non-biologic DMARDs are inferior to biologic DMARDs in phrases of CVD outcomes nonetheless stays not adequately addressed.